Display options
Cite
Hussain MS. Patient counseling about herbal-drug interactions. Afr J Tradit Complement Altern Med. 2011;8(5):152-63doi: 10.4314/ajtcam.v8i5S.8.
Hussain, M. S. (2011). Patient counseling about herbal-drug interactions. African journal of traditional, complementary, and alternative medicines : AJTCAM, 8(5), 152-63. https://doi.org/10.4314/ajtcam.v8i5S.8
Hussain, Md Sarfaraj. "Patient counseling about herbal-drug interactions." African journal of traditional, complementary, and alternative medicines : AJTCAM vol. 8,5 (2011): 152-63. doi: https://doi.org/10.4314/ajtcam.v8i5S.8
Hussain MS. Patient counseling about herbal-drug interactions. Afr J Tradit Complement Altern Med. 2011;8(5):152-63. doi: 10.4314/ajtcam.v8i5S.8. Epub 2011 Jul 03. PMID: 22754069; PMCID: PMC3252717.
Copy Download .nbib Format: NLM
Share it on

Afr J Tradit Complement Altern Med. 2011;8(5):152-63. doi: 10.4314/ajtcam.v8i5S.8. Epub 2011 Jul 03.

Patient counseling about herbal-drug interactions.

African journal of traditional, complementary, and alternative medicines : AJTCAM

Md Sarfaraj Hussain

Affiliations

  1. Faculty of Pharmacy, Integral University, Dasauli, Kurshi road, Lucknow-226026, Uttar Pradesh, India. [email protected]

PMID: 22754069 PMCID: PMC3252717 DOI: 10.4314/ajtcam.v8i5S.8

Abstract

Many people have the mistaken notion that, being natural, all herbs and foods are safe; this is not so. Very often, herbs and food may interact with medications you normally take, result in serious reactions. During the latter part of this century the practice of herbalism has become mainstream throughout the world. This is due remove to the recognition of the value of traditional medical systems in the world. Herbal medicines are mixtures of more than one active ingredient. The multitude of pharmacologically active compounds obviously increases the likelihood of interactions taking place. Hence, the likelihood of herb-drug interactions is theoretically higher than drug-drug interactions because synthetic drugs usually contain single chemical entity. Case reports and clinical studies have highlighted the existence of a number of clinically important interactions, although cause-and-effect relationships have not always been established. Herbs and drugs may interact either pharmacokinetically or pharmacodynamically. The predominant mechanism for this interaction is the inhibition of cytochrome P-450 3A4 in the small intestine; result in a significant reduction of drug presystemic metabolism. An additional mechanism is the inhibition of Pglycoprotein, a transporter that carries drug from the enterocyte back to the gut lumen, result in a further increase in the fraction of drug absorbed. Some herbal products (e.g. St. John's wort) have been shown to lower the plasma concentration (and/or the pharmacological effect) of a number of conventional drugs including cyclosporine, indinavir, irinotecan, nevirapine, oral contraceptives and digoxin. The data available so far, concerning this interaction and its clinical implications are reviewed in this article. It is likely that more information regarding such interaction would crop up in the future, awareness of which is necessary for achieving optimal drug therapy.

Keywords: Cytochrome P-450; Herbal Preparation; Herbal drug; drug-drug interaction; herbal-drug interaction

References

  1. Clin Pharmacol Ther. 2004 Jan;75(1):89-100 - PubMed
  2. J Clin Psychiatry. 2003 May;64(5):609-11 - PubMed
  3. BMJ. 1996 Aug 3;313(7052):253-8 - PubMed
  4. JAMA. 1998 Nov 11;280(18):1569-75 - PubMed
  5. Br J Pharmacol. 2008 Mar;153 Suppl 1:S82-9 - PubMed
  6. Nat Prod Rep. 1997 Apr;14(2):111-44 - PubMed
  7. Chem Rev. 2004 Sep;104(9):3947-80 - PubMed
  8. J Intern Med. 1997 Apr;241(4):337-9 - PubMed
  9. J Arthroplasty. 2005 Jan;20(1):125-6 - PubMed
  10. Pediatr Emerg Care. 1997 Oct;13(5):350-3 - PubMed
  11. AAPS J. 2006 Mar 10;8(1):E101-11 - PubMed
  12. Age Ageing. 2001 Nov;30(6):523-5 - PubMed
  13. Pharmacotherapy. 1999 Jul;19(7):870-6 - PubMed
  14. Ann Pharmacother. 2004 Feb;38(2):257-60 - PubMed
  15. Nutr Clin Pract. 2005 Feb;20(1):33-51 - PubMed
  16. JAMA. 1971 Dec 27;218(13):1924-7 - PubMed
  17. Atherosclerosis. 2003 Apr;167(2):367 - PubMed
  18. Aust N Z J Med. 1995 Jun;25(3):258 - PubMed
  19. Diabetes Care. 2000 Sep;23(9):1221-6 - PubMed
  20. J Psychopharmacol. 2002 Dec;16(4):401 - PubMed
  21. Ann Pharmacother. 1995 Dec;29(12):1274-83 - PubMed
  22. Ceylon Med J. 2002 Mar;47(1):19-21 - PubMed
  23. Int J Clin Pharmacol Ther. 2004 Mar;42(3):139-48 - PubMed
  24. Am Fam Physician. 1999 Mar 1;59(5):1239-45 - PubMed
  25. Acad Emerg Med. 2002 Nov;9(11):1162-7 - PubMed
  26. J Am Geriatr Soc. 2001 Jun;49(6):838 - PubMed
  27. Phytomedicine. 2003 Nov;10(8):688-99 - PubMed
  28. Expert Opin Drug Metab Toxicol. 2005 Oct;1(3):487-503 - PubMed
  29. Ann Thorac Surg. 1998 Sep;66(3):941-2 - PubMed
  30. Mol Psychiatry. 1999 Jul;4(4):333-8 - PubMed
  31. Expert Opin Pharmacother. 2005 Feb;6(2):233-53 - PubMed
  32. J Pharmacol Exp Ther. 2006 Mar;316(3):1369-77 - PubMed
  33. Protein Eng. 1995 Aug;8(8):737-47 - PubMed
  34. Prog Clin Biol Res. 1986;213:545-58 - PubMed
  35. Life Sci. 2006 Mar 27;78(18):2146-57 - PubMed
  36. Ann Intern Med. 1998 Dec 15;129(12):1061-5 - PubMed
  37. Expert Opin Drug Metab Toxicol. 2005 Dec;1(4):641-54 - PubMed
  38. Br J Clin Pharmacol. 2002 Jan;53(1):75-82 - PubMed
  39. Fundam Clin Pharmacol. 2005 Feb;19(1):1-16 - PubMed
  40. Cell Mol Neurobiol. 1999 Jun;19(3):309-23 - PubMed
  41. Lancet. 2002 Oct 12;360(9340):1155-62 - PubMed
  42. Kathmandu Univ Med J (KUMJ). 2007 Jul-Sep;5(3):421-30 - PubMed
  43. Am J Med. 2002 Oct 15;113(6):506-15 - PubMed
  44. Adv Pharmacol. 1997;43:7-35 - PubMed
  45. J Clin Psychopharmacol. 2002 Feb;22(1):46-54 - PubMed
  46. Pharmacopsychiatry. 1997 Sep;30 Suppl 2:77-80 - PubMed
  47. J Altern Complement Med. 2002 Jun;8(3):293-308 - PubMed
  48. J Pharm Pharmacol. 1995 May;47(5):402-6 - PubMed
  49. Br J Clin Pharmacol. 1998 May;45(5):496-500 - PubMed
  50. Drug Metab Rev. 1979;9(2):221-36 - PubMed
  51. Br J Clin Pharmacol. 2001 Nov;52(5):587-95 - PubMed
  52. Am J Ther. 2006 Jan-Feb;13(1):24-31 - PubMed
  53. Transplantation. 2001 Jan 27;71(2):239-41 - PubMed
  54. Eur J Drug Metab Pharmacokinet. 1995 Jan-Mar;20(1):55-60 - PubMed
  55. Genome Biol. 2000;1(6):REVIEWS3003 - PubMed
  56. Arzneimittelforschung. 1993 Feb;43(2):119-22 - PubMed
  57. Drugs. 1987;34 Suppl 1:159-69 - PubMed
  58. Br J Clin Pharmacol. 2004 May;57(5):592-9 - PubMed

Substances

MeSH terms

Publication Types